Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-14-000346
Filing Date
2014-03-28
Accepted
2014-03-28 12:03:28
Documents
2
Period of Report
2014-03-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2962
2 POWER OF ATTORNEY FOR THEODORE ALAN HUIZENGA RE ULTRAGENYX PHARMACEUTICAL INC. huizenga032414ultragenyx-poa.htm EX-24 11539
  Complete submission text file 0000904454-14-000346.txt   15803
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address
Huizenga Theodore Alan (Reporting) CIK: 0001603347 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36276 | Film No.: 14724285